Accredited CPD activity for pharmacists on biosimilar medicines

Accredited CPD Activity for Pharmacists

Biosimilar medicines: information for pharmacists

This activity addresses the following learning objectives using a combination of reading and active listening to video content:

EXPERTISE	Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines
PATIENT CARE	Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product Provide evidence-based information to manage patient concerns and queries surrounding biosimilar medicines
PRACTICE	Define the criteria that must be met in order to substitute a PBS-subsidised reference biological with a biosimilar medicine at the point of dispensing

Achievement of these learning objectives demonstrates competency in the following domains of pharmacy practice:¹

1. Professionalism and ethics
1.5 Apply expertise in professional practice

2. Communication and collaboration
   2.2 Collaborate with professional colleagues
   2.3 Communicate effectively
   2.4 Apply interpersonal communication skills to address problems

3. Medicines management and patient care
3.5 Support Quality Use of Medicines

Reference: 1. Pharmaceutical Society of Australia. National Competency Standards Framework for Pharmacists in Australia 2016.

This activity has been accredited for 1 hour of Group 1 CPD (or 1 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1 hour of Group 2 CPD (2 CPD credits) upon successful completion of relevant assessment activities.

Accreditation number: CX19042 .